ARCA biopharma, Inc. Human Resources Contracts & Agreements
43 Contracts & Agreements
- Bonus & Incentive Agreements (29 contracts)
- Change of Control Agreements (1)
- Consulting Agreements (2)
- Employment Agreements (9)
- Separation Agreements (1)
- Severance Agreements (1)
- Amended and Restated Employment Letter Agreement by and between the Company and Arjun Agarwal, dated as of October 3, 2024 (Filed With SEC on October 4, 2024)
- Amended and Restated Employment Letter Agreement by and between the Company and Dr. Lawrence Klein, dated as of October 3, 2024 (Filed With SEC on October 4, 2024)
- Consulting Agreement, effective as of August 30, 2024, by and between Oruka Therapeutics, Inc. and Jeff Dekker (Filed With SEC on September 5, 2024)
- Second Amendment to Amended and Restated Oruka Therapeutics, Inc. 2024 Equity Incentive Plan, effective as of May 7, 2024 (Filed With SEC on September 5, 2024)
- Oruka Therapeutics, Inc. 2024 Stock Incentive Plan (Filed With SEC on September 5, 2024)
- Employment Offer Letter, dated April 12, 2024, by and between Oruka Therapeutics, Inc. and Paul Quinlan (Filed With SEC on May 14, 2024)
- Employment Offer Letter, dated March 15, 2024, by and between Oruka Therapeutics, Inc. and Joana Goncalves (Filed With SEC on May 14, 2024)
- Employment Offer Letter, dated March 11, 2024, by and between Oruka Therapeutics, Inc. and Arjun Agarwal (Filed With SEC on May 14, 2024)
- Amended and Restated Employment Offer Letter, dated February 14, 2024, by and between Oruka Therapeutics, Inc. and Lawrence Klein (Filed With SEC on May 14, 2024)
- Form of Stock Option Agreement under Oruka Therapeutics, Inc. 2024 Equity Incentive Plan (Filed With SEC on May 14, 2024)
- Amended and Restated Oruka Therapeutics, Inc. 2024 Equity Incentive Plan, as amended by the First Amendment dated May 7, 2024 (Filed With SEC on May 14, 2024)
- Second Amendment to Retention Bonus Letter, dated April 22, 2024, by and between ARCA biopharma, Inc. and C. Jeffrey Dekker (Filed With SEC on April 23, 2024)
- Second Amendment to Retention Bonus Letter, dated April 22, 2024, by and between ARCA biopharma, Inc. and Thomas A. Keuer (Filed With SEC on April 23, 2024)
- Consulting Agreement, by and between ARCA and Michael Bristow, dated as of April 3, 2024 (Filed With SEC on April 4, 2024)
- Separation Agreement and Release, by and between ARCA and Michael Bristow, dated as of April 3, 2024 (Filed With SEC on April 4, 2024)
- Amendment to Retention Bonus Letter, dated December 4, 2023, by and among ARCA biopharma, Inc. and C. Jeffrey Dekker (Filed With SEC on December 4, 2023)
- Amendment to Retention Bonus Letter, dated December 4, 2023, by and among ARCA biopharma, Inc. and Thomas A. Keuer (Filed With SEC on December 4, 2023)
- Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and C. Jeffrey Dekker dated December 8, 2022 (Filed With SEC on December 9, 2022)
- Memorandum Regarding Cash Retention Bonus between ARCA biopharma, Inc. and Thomas A. Keuer dated December 8, 2022 (Filed With SEC on December 9, 2022)
- Employment Agreement, dated April 21, 2021, by and between ARCA biopharma, Inc. and C. Jeff Dekker (Filed With SEC on May 11, 2021)
- Form of Restricted Stock Unit Award Agreement and Notice of Grant Award under 2020 Equity Incentive Plan (Officer) (Filed With SEC on December 23, 2020)
- Form of Restricted Stock Unit Award Agreement and Notice of Grant Award under 2020 Equity Incentive Plan (Standard) (Filed With SEC on December 23, 2020)
- Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Director) (Filed With SEC on December 23, 2020)
- Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Officer) (Filed With SEC on December 23, 2020)
- Form of Stock Option Agreement and Option Grant Notice under 2020 Equity Incentive Plan (Standard) (Filed With SEC on December 23, 2020)
- ARCA biopharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on December 10, 2020)
- ARCA BIOPHARMA, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. STOCK OPTION GRANT NOTICE (2013 EQUITY INCENTIVE PLAN) (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. 2013 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JULY 26, 2013 APPROVED BY THE STOCKHOLDERS:SEPTEMBER 17, 2013 EFFECTIVE DATE: SEPTEMBER 17, 2013 (Filed With SEC on September 23, 2013)
- ARCA BIOPHARMA, INC. SEVERANCE BENEFIT PLAN (Filed With SEC on August 10, 2009)
- ARCA DISCOVERY, INC. 2004 STOCK INCENTIVE PLAN (Filed With SEC on January 28, 2009)
- ARCA BIOPHARMA, INC. 2004 STOCK INCENTIVE PLAN (Filed With SEC on January 28, 2009)
- ARCADISCOVERY, INC. 2004 STOCK INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on January 28, 2009)
- ARCA DISCOVERY, INC. 2004 STOCK INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on January 28, 2009)
- AMENDED AND RESTATED ADDENDUM TO EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2008)
- NUVELO, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN (Filed With SEC on November 7, 2007)
- AMENDED AND RESTATED ADDENDUM TO EMPLOYMENT AGREEMENT (Filed With SEC on November 7, 2007)
